EANS-Adhoc: Intercell reports positive results from its Phase II Pseudomonas aeruginosa investigational vaccine study for certain hospital acquired infections
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Research & Development 25.10.2010 » Primary Immunogenicity and Safety Endpoints met » Significant reduction of mortality observed versus alum ...